P Moreau, N Robillard, H Avet-Loiseau, D Pineau, N Morineau, N Milpied, JL Harousseau, R Bataille. Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma. haematol [Internet]. 2004May1 [cited 2024Dec.22];89(5):547-51. Available from: https://haematologica.org/article/view/3076